Treatment of resistant chronic migraine with anti-CGRP monoclonal antibodies: a systematic review
Background: Resistant chronic migraine is a highly disabling condition which is very difficult to treat. The existing prophylactic treatments for migraine are nonspecific and present weak safety profiles, leading to low adherence and discontinuation. Currently, monoclonal antibodies (mAb) targeting...
| Autor principal: | |
|---|---|
| Formato: | masterThesis |
| Idioma: | eng |
| Publicado em: |
2022
|
| Assuntos: | |
| Texto completo: | https://hdl.handle.net/10216/142121 |
| País: | Portugal |
| Oai: | oai:repositorio-aberto.up.pt:10216/142121 |